GREY:ATBPF - Post by User
Comment by
IrishCanuckon Dec 04, 2020 11:54am
216 Views
Post# 32037314
RE:Updates from Dan
RE:Updates from DanMost in vivo toxicology studies don't take long and we have had six months pass since Phase 2 was released. I hope they initiated long term toxicology for carcinogenesis long before June or else we'll be waiting a few years... but considering Otenaproxesul is based on compounds naturally produced in the body for cell signalling you could very quickly reduce that parameter timeframe with any reasonable regulatory body.
Some of the 9 studies could be run alongside each other, some can only be started based on the results of prior studies. I wonder what the cohort sizes are, but that last study he said would start "next week" fingers crossed it the last one. We could very easily see the end of these studies by the end of this month.
As everything from the RS has been sorted out for the stock market now let's hope there is a news release on Monday. They have recently jampacked their website with information. I'm just as excited for ATB-352 updates as Otenaproxesul as both should move the needle, obviously Phase 3 being the catalyst